Crossword Solver > found answer > MERSETIN

Welcome to Anagrammer Crossword Genius! Keep reading below to see if mersetin is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on mersetin.

CROSSWORD
ANSWER

mersetin

Searching in Crosswords ...

The answer MERSETIN has 0 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word MERSETIN is NOT valid in any word game. (Sorry, you cannot play MERSETIN in Scrabble, Words With Friends etc)

There are 8 letters in MERSETIN ( E¹I¹M³N¹R¹S¹T¹ )

To search all scrabble anagrams of MERSETIN, to go: MERSETIN

Rearrange the letters in MERSETIN and see some winning combinations

6 letters out of MERSETIN

5 letters out of MERSETIN

4 letters out of MERSETIN

3 letters out of MERSETIN

EME EMS ENS ERE ERN ERS INS IRE ISM ITS MEN MET MIR MIS NEE NET NIM NIT REE REI REM RES RET RIM RIN SEE SEI SEN SER SET SIM SIN SIR SIT SRI TEE TEN TIE TIN TIS

2 letters out of MERSETIN

EM EN ER ES ET IN IS IT ME MI NE RE SI TI

Searching in Dictionaries ...

Definitions of mersetin in various dictionaries:

No definitions found

Word Research / Anagrams and more ...

Keep reading for additional results and analysis below.

Mersetin might refer to
Merestinib (LY2801653) is an experimental cancer drug in development by Eli Lilly. It is a small molecule inhibitor of MET and several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2. * Meristinib is part of a phase II clinical trial for advanced billiary tract cancer. The study is expected to be complete in April 2018. Phase II clinical trials for non-small cell lung cancer and solid tumors began in November 2016.

Mersetin might refer to

Merestinib (LY2801653) is an experimental cancer drug in development by Eli Lilly. It is a small molecule inhibitor of MET and several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2.
* Meristinib is part of a phase II clinical trial for advanced billiary tract cancer. The study is expected to be complete in April 2018. Phase II clinical trials for non-small cell lung cancer and solid tumors began in November 2016.

Anagrammer Crossword Solver is a powerful crossword puzzle resource site. We maintain millions of regularly updated crossword solutions, clues and answers of almost every popular crossword puzzle and word game out there. We encourage you to bookmark our puzzle solver as well as the other word solvers throughout our site. Explore deeper into our site and you will find many educational tools, flash cards and plenty more resources that will make you a much better player. Mersetin: Merestinib (LY2801653) is an experimental cancer drug in development by Eli Lilly. It is a small mol...